Literature DB >> 350396

Empiric antibiotic therapy.

S C Schimpff, J Aisner.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 350396

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  6 in total

1.  [Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients].

Authors:  B E de Pauw
Journal:  Infection       Date:  1987       Impact factor: 3.553

2.  Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.

Authors:  L A Cone; D R Woodard; D S Stoltzman; R G Byrd
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

3.  Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients.

Authors:  B S Kramer; R Ramphal; K H Rand
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

4.  Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.

Authors:  F Menichetti; A Del Favero; R Guerciolini; M Tonato; F Aversa; F Roila; R F Frongillo; M F Martelli; S Davis; S Pauluzzi
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

Review 5.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

6.  Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination.

Authors:  S de Marie; P J van den Broek; R Willemze; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.